24 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

SLV

Selvita
zł68.00-0.7%-9.3%zł1.2bzł71.28PE17.9xE13.8%n/a

RVU

Ryvu Therapeutics
zł48.85-4.2%-12.8%zł1.1bzł73.13PS16.8xE-10.7%n/a

CLN

Celon Pharma
zł15.241.6%9.6%zł778.1mzł16.50PS3.6xE78.7%0.6%

CTX

Captor Therapeutics Spolka Akcyjna
zł79.80-0.3%-51.6%zł370.7mzł115.00PS29.6xE109.8%n/a

SVE

Synthaverse
zł4.97-0.8%-15.8%zł350.5mn/aPE73.7xn/an/a

BIO

BIOTON
zł3.51-0.4%-11.3%zł301.0mn/aPE132.3xn/an/a

BCX

Bioceltix
zł67.10-3.2%3.5%zł277.1mn/aPB19.5xn/an/a

MAB

Mabion
zł16.24-3.6%-12.0%zł262.5mzł15.83PE6.4xE-103.2%n/a

MOC

Molecure
zł14.72-1.6%-34.4%zł247.8mzł34.00PS180.1xE-6.3%n/a

PTG

Poltreg
zł48.70-6.0%-9.5%zł227.1mzł68.20PS162.3xE8.2%n/a

GMT

Genomtec
zł12.12-5.2%38.0%zł148.6mn/aPS7819.2xn/an/a

URT

Urteste
zł97.80-1.2%-25.3%zł137.9mn/an/an/an/a

RDG

Read-Gene
zł5.560.7%63.5%zł65.6mn/aPS6.5xn/an/a

BGD

Biogened
zł25.00-3.1%81.2%zł61.4mn/aPE14.6xn/a1.6%

MDB

Medicofarma Biotech
zł0.90-3.0%-13.5%zł61.2mn/aPS81.5xn/an/a

GEN

Genomed Spólka Akcyjna
zł29.600%-27.8%zł39.1mn/aPE39.4xn/a0%

CBD

Cannabis Poland
zł0.593.7%63.7%zł28.8mn/aPS439.9xn/an/a

PUR

Pure Biologics
zł7.80-1.9%-55.4%zł26.0mn/aPS238.1xn/an/a

GX1

genXone
zł7.182.6%-17.1%zł23.7mn/aPS9.9xn/a0%

SCS

Stem Cells Spin
zł0.49-2.0%18.9%zł20.3mn/aPS48.3xn/an/a

NNG

NanoGroup
zł1.01-1.5%-16.3%zł20.2mn/aPB2.7xn/an/a

BER

Bioerg Spólka Akcyjna
zł0.140%-17.6%zł13.8mn/aPS46.1xn/an/a

IGN

Inno-Gene
zł1.70-5.3%-66.7%zł10.5mn/aPS9.3xn/an/a

LCN

Labocanna
zł0.432.6%-13.7%zł9.1mn/aPS549.2xn/an/a
Page 1 of 1
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.